← Every company
argenx SE SEC Filings
What argenx SE has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
ARGX overview →Filings on file
14
since Apr 21, 2017
Warning signs
0
none filed
Last results
—
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 6, 2026 | Tender offer SC TO-T | Read ↗ |
| Mar 19, 2026 | Annual report 20-F | Read ↗ |
| Mar 20, 2025 | Annual report 20-F | Read ↗ |
| Mar 21, 2024 | Annual report 20-F | Read ↗ |
| Mar 16, 2023 | Annual report 20-F | Read ↗ |
| Mar 21, 2022 | Annual report 20-F | Read ↗ |
| Mar 30, 2021 | Annual report 20-F | Read ↗ |
| Mar 31, 2020 | Annual report 20-F | Read ↗ |
| Mar 26, 2019 | Annual report 20-F | Read ↗ |
| Mar 26, 2018 | Annual report 20-F | Read ↗ |
| Dec 14, 2017 | Share offering 424B4 | Read ↗ |
| Dec 11, 2017 | Share offering F-1 | Read ↗ |
| May 19, 2017 | Share offering 424B4 | Read ↗ |
| Apr 21, 2017 | Share offering F-1 | Read ↗ |
Source: argenx SE's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.